Uncategorized

Ozempic reduces major cardiovascular events by 20% in high-risk patients, but proper monitoring matters. Here’s what the SELECT trial actually shows.

Ozempic (semaglutide) showed 59% NASH resolution versus 17% placebo in NEJM-published trials — liver fat reduction extends beyond weight loss alone.

Ozempic improves insulin sensitivity through GLP-1 receptor activation, reducing hepatic glucose output and enhancing peripheral glucose uptake in muscle

Ozempic (semaglutide) reduces LDL cholesterol by 3–7% and triglycerides by 12–25% through enhanced incretin signaling and reduced hepatic lipid production.

Semaglutide reduces liver fat by up to 40% in NAFLD patients — through mechanisms beyond weight loss alone. Here’s what the clinical evidence shows.

The Ozempic maintenance dose typically ranges from 0.5mg to 1.0mg weekly to sustain weight loss and glycemic control after initial titration completes.

Ozempic doesn’t directly treat thyroid conditions but carries specific thyroid-related risks including rare medullary thyroid carcinoma warnings requiring

Ozempic and statins can be taken together safely under medical supervision — no direct drug interaction exists, but both affect metabolic pathways

Cycling off Ozempic requires 4–8 weeks of careful dose reduction to minimize rebound hunger and weight regain — here’s the medically-supported process.